NICHOLAS WALDHAUS: Open Payments
NPI 1275183717 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $262 · 2025 $203
Food & beverage: $204
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $106 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| ABBVIE INC. | 1 | $29 |
| Alkermes, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $18 |
Products named: INGREZZA, INVEGA SUSTENNA, VRAYLAR, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across MD — which companies pay providers there.
